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During rat liver regeneration i duced by carbon tetrachloride administration, the protein kinase C a subspecies was acti- 
vated in a heterogeneous fashion, a higher number of hepatocytes expressing the protein kinase C a subspecies being 
detected in the pericentral zone than in the periportal zone. This zonal heterogeneity became maximal at 24 h after the 
treatment. The distribution of hepatocytes expressing the protein kinase C a subspecies was roughly coincident with that 
of hepatocytes exhibiting DNA synthesis. These results suggest hat protein kinase C may play a crucial role in liver 
regeneration. 
Protein kinase C; Liver regeneration; Carbon tetrachloride administration; DNA synthesis 
1. INTRODUCTION 
Liver regeneration provides a good model for 
studying cell growth and differentiation in an ‘in 
vivo’ physiologically controlled situation. Various 
hepatotrophic factors exert their actions in 
regenerating liver by changing the intracellular 
concentrations of ‘second messengers’ such as 
Ca2+, cyclic AMP and cyclic GMP [l-3]. These 
second messengers, in turn, have effects on specific 
enzymes, receptors and other proteins, leading to 
the generation of physiological responses. On the 
other hand, PKC plays a crucial role in signal 
transduction for a variety of biologically active 
substances which trigger cellular functions and 
proliferation [4]. This enzyme is present in various 
tissues and cell types [5], and is usually activated by 
1,2-diacylglycerol, which is released during the 
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process of phosphoinositide breakdown induced by 
receptor-mediated stimulation of many kinds of 
hormones, neurotransmitters and growth factors 
[6]. Accordingly, PKC may share the second 
messengers involved in liver regeneration and play 
an important role in mediating the biological ac- 
tions of hepatotrophic factors. In this study, 
purification of PKC and immunohistochemical 
analysis were performed to determine whether, and 
if so how, PKC is activated in a hepatic lobule dur- 
ing liver regeneration induced by CC 14 administra- 
tion. 
2. MATERIALS AND METHODS 
2.1. Preparation of animals 
Fifty-one male Sprague-Dawley rats, weighing 200-250 g, 
were used in this study. In order to induce liver regeneration, 
forty-five rats were given a single intragastric dose, 0.5 ml, of a 
1:l (v/v) mixture of CC4 in mineral oil per 100 g body weight, 
intragastrically. No treatment except mineral oil administration 
(1 ml per 100 g body weight) was given to the remaining six rats, 
which formed the normal group. At 24 h, 48 h and 7 days after 
the treatment, three rats were processed for the partial purifica- 
tion of PKC. On the other hand, at 6 h, 12 h, 24 h, 48 h, 72 h 
and 7 days after the administration, three fasted rats were sub- 
jected to immunohistochemical nalysis of PKC. In order to 
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detect DNA replication after CC4 administration, the other 
three rats were injected intravenously with BrdU [7] at the dose 
of 30 mg/kg body weight 1 h before being killed. The rats in the 
normal group were similarly prepared. The protocol for this 
study was approved by the Animal Studies Committee of Osaka 
University. 
2.2. Enzyme purification and assays 
Rat liver PKC was purified and resolved into two fractions, 
types II and III, by chromatography on a hydroxyapatite col- 
umn, which was connected to a high-performance liquid 
chromatography (Pharmacia FPLC) system, under the condi- 
tions described previously [8]. The type II and III PKCs corre- 
spond to the fl I- plus fi II- and LY subspecies, respectively [9]. 
PKC was assayed by measuring the incorporation of ‘*Pi into 
Hr histone from [y-“P]ATP in the presence of phosphatidyl- 
serine (8 ,cg/ml), diolein (0.8 pg/ml) and CaClz (0.5 mM) under 
the conditions given previously [8]. Basal activity was measured 
in the presence of 0.5 mM EGTA instead of phosphatidylserine, 
diolein and Ca’+. Protein contents were determined by the 
method of Lowry et al. [lo]. 
2.3. Immunohistochemical analysis 
The procedures and conditions for immunohistochemical 
analysis in this study were described in detail elsewere [11,121. 
Using synthetic oligopeptides pecific for the predicted amino 
acid sequences of the C-terminal portions of the PKC LY, fl I- 
and p II-subspecies (cu peptide residues 662-672; p I-peptide 
residues 661-671; ,i3 II-peptide residues 660-673), polyclonal an- 
tisera were raised in New Zealand White rabbits. Detailed pro- 
cedures and properties of these antisera were described [13,14]. 
Sections from rats injected with BrdU were examined for DNA 
replication with a cell proliferation kit (Amersham, UK). 
3. RESULTS 
3.1. Partial purification of PKC 
Fig. 1 shows representative hydroxyapatite col- 
umn chromatography of PKC from normal and 
treated rat livers. Two distinct types of PKC activi- 
ty were obtained. The material of the first and sec- 
ond peaks from liver was eluted in fractions 30 
through 38, and fractions 50 through 64, respec- 
tively, and this elution profile was highly 
reproducible. The activity of the material of the se- 
cond peak increased to a peak at 24 h and then 
decreased, having returned to an almost basal level 
Fraction Number 
Fig. 1. Hydroxyapatite column chromatography of PKC from 
normal and treated rat livers. Rat liver PKC was purified by 
DE-52 and hydroxyapatite column chromatographies, and the 
fractions from the hydroxyapatite column were assayed as 
described in section 2. PKC from normal liver (A), liver 24 h 
after CCL administration (B), liver 48 h after CC4 administra- 
tion (C), and liver 7 days after CCL administration (D). 
(o----+) PKC activity in the presence of phosphatidylserine, 
diolein and CaClz; (M) PKC activity in the presence of 
EGTA instead of phosphatidylserine, diolein and Car&; 
(- - -) potassium phosphate. 
7 days after treatment, while that of the first peak 
material remained almost unchanged. The kinase 
activity in these fractions was almost entirely Ca*+- 
and phospholipid-dependent . 
3.2 Immunohistochemical detection of PKC and 
DNA replication 
In normal liver, hepatocytes immunostained for 
the PKC LY subspecies were diffusely distributed 
within a hepatic lobule (fig.2A). Immunoreactive 
structures were mainly localized in cell membranes 
of hepatocytes. The observation for the PKC p I- 
or PKC ,& II-subspecies was similar to that for the 
PKC CY subspecies (data not shown). At 6 h after 
CC4 administration, heterogeneity of immuno- 
Fig.2. Immunohistochemical localization of the PKC (Y subspecies in normal rat liver and rat liver at 6 h after CCL administration. In 
normal liver, hepatocytes immunostained for the PKC LY subspecies are diffusely distributed within a hepatic lobule (A). Immunoreac- 
tive structures are mainly localized in the cell membranes of hepatocytes. Heterogeneity of immunostaining first becomes evident at 
6 h after the treatment. The few hepatocytes tained for the PKC a subspecies are detected predominantly in the pericentral and 
mediolobular zones (B). Immunoreactive structures in these cells are localized not only in the cell membrane but also throughout he 
cytoplasm. Magnification: x 90 in A; x 45 in B. 
60 
Volume 254, number 1,2 FEBS LETTERS August 1989 
61 
” 
Volume 254, number 1,2 FEBS LETTERS August 1989 
62 
Volume 254, number 1,2 FEBS LETTERS August 1989 
Fig.3. Immunohistochemical localization of the PKC a subspecies in rat liver at 24 h after CCL, administration. The number of 
hepatocytes immunostained for the PKC (Y subspecies has become maximal, with the development of clear zonal heterogeneity (A). Note 
that macrophages are also stained for the PKC LY subspecies (B, arrows). Control reactions involving incubation with rabbit IgG instead 
of the first antiserum (C) and omission of the first antiserum (data not shown) are negative. Magnification: x 25 in A; x 50 in B, C. 
staining first became evident. The few hepatocytes 
were intensely stained for the PKC cy subspecies, 
predominantly in the pericentral and mediolobular 
zones (fig.2B). Immunoreactive structures in these 
cells were localized not only in the cell membrane 
but also throughout the cytoplasm. At 24 h after 
treatment, the number of hepatocytes tained for 
the PKC (Y subspecies (fig.3A) became maximal, 
with the development of clear zonal heterogeneity. 
Immunostained hepatocytes were observed around 
Fig.4. Immunohistochemical localization of PKC and BrdU in rat liver at 48 h after CCL administration. Hepatocytes immunostained 
for the PKC (Y subspecies can be seen around areas showing a fatty change and/or ballooning in the pericentral and mediolobular zones 
(A). Heterogeneous taining is also evident for the PKC j3 I- (B) or fi II- (C) subspecies, but the intensity of immunostaining is very 
weak compared with the case of the PKC (Y subspecies. The nuclei of some hepatocytes are immunostained for BrdU, which is indicative 
of ongoing DNA synthesis (D). The labeled nuclei are detected around areas showing pathological changes. Magnification: x 32.5 in 
A, B, C; x 16.3 in D. 
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areas where cell necrosis and/or a fatty change 
were observed. In addition, macrophages were also 
intensely stained for the PKC cy subspecies (fig.3B, 
arrows). Control reactions involving incubation 
with rabbit IgC instead of the first antiserum 
(fig.3C) and omission of the first antiserum (data 
not shown) were negative. At 48 h after ad- 
ministration, hepatocytes immunostained for the 
PKC LY subspecies were detected around areas 
showing a fatty change and/or ballooning in the 
pericentral and mediolobular zones (fig.4A). The 
number of immunostained hepatocytes was 
descreased, as compared with that at 24 h after 
treatment, while the zonal heterogeneity of im- 
munostaining remained. A heterogeneous im- 
munostaining pattern was also recorded for the 
PKC p I- (fig. 4B) or p II- (fig.4C) subspecies, 
whereas the intensity of immunostaining was weak 
compared with the case of the PKC (Y subspecies. 
On the other hand, the nuclei of some hepatocytes 
were stained for BrdU, which was indicative of 
ongoing DNA synthesis (fig.4D). The labeled 
nuclei were detectable predominantly around areas 
showing pathological changes in the mediolobular 
and pericentral zones. Finally, at 72 h after treat- 
ment , immunoreactive structures were only 
detected in the cell membrane of hepatocytes, as 
observed in normal liver (data not shown). 
PKC enzyme assaying and immunohistochemical 
analysis indicate that the contribution of the PKC 
/3 I- and ,8 II-subspecies to liver regeneration is 
negligible, compared with that of the PKC cy sub- 
species. The precise mechanisms underlying activa- 
tion of the PKC LY subspecies and its functional 
roles in hepatocytes during liver regeneration re- 
main unknown. Some of the hepatotrophic factors 
would cause the receptor-mediated hydrolysis of 
inositol phospholipids, resulting in activation of 
PKC. Vasopressin, angiotensin and epinephrine, 
defined as competence factors for cellular growth 
[15], may activate PKC, and then the activated 
PKC may mediate the sequence of early events in 
cellular proliferation of the liver, as speculated for 
various tissues and cell lines [6,16-2 11. In addition, 
the activated PKC modulates binding and the 
phosphorylation of receptors for EGF [22,23], 
which is defined as a progression factor [15]. The 
modulation of the EGF receptor by PKC may pro- 
vide a mechanism whereby competence factor(s) 
and progression factor(s) can act sequentially in 
stimulating cell growth. In this way, activation of 
PKC during liver regeneration may mediate and 
regulate the sequence of events concerning the 
competence and progression of cellular prolifera- 
tion of the liver. Further investigations are required 
to clarify the functional role of the PKC (Y 
subspecies during liver regeneration. 
4. DISCUSSION 
The present study is the first demonstration that 
the activity of the PKC (Y subspecies increased prior 
to the initiation of DNA synthesis during liver 
regeneration induced by CC14 administration. This 
change in the activity of the PKC LY subspecies up- 
ported the finding on immunohistochemical 
analysis that the number of immunostained 
hepatocytes increased, with a peak at 24 h after 
CC4 administration, followed by DNA synthesis. 
Immunohistochemicaf analysis also showed that 
the PKC (Y subspecies was activated around areas 
showing pathological changes, and the distribution 
of hepatocytes expressing the PKC cy subspecies 
was roughly coincident with that of those ex- 
hibiting DNA synthesis. Taking all the results 
together, it is suggested that the PKC cy subspecies 
is the dominant PKC subspecies involved in crucial 
events regulating cell growth during liver regenera- 
tion. On the other hand, the present findings on 
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